Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma

In multiple myeloma, novel treatments with proteasome inhibitors (PIs) and immunomodulatory agents (IMiDs) have prolonged survival but the disease remains incurable. At relapse, next-generation sequencing has shown occasional mutations of drug targets but has failed to identify unifying features tha...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Blood Adv
Главные авторы: Ziccheddu, Bachisio, Biancon, Giulia, Bagnoli, Filippo, De Philippis, Chiara, Maura, Francesco, Rustad, Even H., Dugo, Matteo, Devecchi, Andrea, De Cecco, Loris, Sensi, Marialuisa, Terragna, Carolina, Martello, Marina, Bagratuni, Tina, Kastritis, Efstathios, Dimopoulos, Meletios A., Cavo, Michele, Carniti, Cristiana, Montefusco, Vittorio, Corradini, Paolo, Bolli, Niccolo
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Hematology 2020
Предметы:
Lymphoid Neoplasia
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7065476/
https://ncbi.nlm.nih.gov/pubmed/32126144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000779
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы